TLDR CoreWeave CDO McBee Brannin sold ~$5 million in Class A stock on April 27, 2026, under a pre-planned Rule 10b5-1 trading plan. A second insider, Brian VenturoTLDR CoreWeave CDO McBee Brannin sold ~$5 million in Class A stock on April 27, 2026, under a pre-planned Rule 10b5-1 trading plan. A second insider, Brian Venturo

CoreWeave (CRWV) Stock: Two Insiders Sell Over $45 Million in One Day

2026/05/01 02:09
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

TLDR

  • CoreWeave CDO McBee Brannin sold ~$5 million in Class A stock on April 27, 2026, under a pre-planned Rule 10b5-1 trading plan.
  • A second insider, Brian Venturo, sold 375,000 shares for roughly $40.9 million, also under a pre-arranged plan.
  • CRWV stock traded up about 8.2% to $114.19 on heavy volume, and is up 59% year-to-date.
  • Analyst sentiment is broadly positive, with 20 Buy ratings and an average price target of $125.78.
  • CoreWeave recently signed a $6 billion compute deal with Jane Street, and earnings are scheduled for May 7.

CoreWeave stock is up 59% year-to-date and trades around $114, but two company insiders just cashed in big — and the market barely flinched.


CRWV Stock Card
CoreWeave, Inc. Class A Common Stock, CRWV

On April 27, 2026, Chief Development Officer McBee Brannin sold approximately $5 million worth of Class A Common Stock. The 45,850 shares were sold at prices ranging from $105.02 to $112.76 per share.

The sales were executed under a Rule 10b5-1 trading plan Brannin adopted back in November 2025. These pre-scheduled plans are set up in advance to avoid accusations of trading on inside information.

The shares were held indirectly through two grantor retained annuity trusts — the Canis Major 2025 GRAT and the Canis Minor 2025 GRAT — a common estate planning structure.

That same day, a second insider, Brian Venturo, sold 375,000 shares at an average price of $109.03, totaling roughly $40.9 million. That transaction was also carried out under a pre-arranged 10b5-1 plan.

Combined, the two insiders offloaded more than $45 million in stock in a single day.

Stock Reaction and Recent Performance

Despite the heavy insider selling, CRWV traded up 8.2% to $114.19 on the day, with volume close to its 27.8 million share average. The stock has a 12-month range of $39.50 to $187.00, putting the current price roughly in the middle of that range.

Year-to-date, CRWV is up 59%. Over the past year it has surged 176%, though it slipped 2.8% in the most recent week.

The company carries a market cap of around $50–57 billion depending on the day of measurement. Its debt-to-equity ratio sits at 4.46, and it remains unprofitable, reporting a loss of $0.89 per share in its last quarter — worse than the $0.61 loss analysts had expected.

Revenue for that quarter came in at $1.57 billion, up 110.4% year-over-year.

Analysts Still Mostly Bullish

Wall Street has not been scared off by the losses or the insider sales. Of 33 analysts covering the stock, 20 rate it a Buy, 11 a Hold, and just 2 a Sell. The average price target stands at $125.78.

Wells Fargo recently raised its target to $135 with an Overweight rating. DA Davidson went further, lifting its target to $175 with a Buy. Cantor Fitzgerald raised its target from $149 to $156 following a $6 billion compute agreement CoreWeave signed with Jane Street.

Under that deal, Jane Street will use CoreWeave’s compute capacity across multiple facilities. It also invested $1 billion in CoreWeave at $109 per share.

Oppenheimer said it expects CoreWeave to report Q1 revenue near the top of its guidance range and potentially raise its 2026 outlook.

On the more cautious side, Sanford C. Bernstein raised its target from $56 to $67 but kept an Underperform rating.

CoreWeave has also priced a $1 billion private offering of senior notes due 2031 at an interest rate of 9.75%, expected to close April 21, 2026.

Earnings are scheduled for May 7, 2026.

The post CoreWeave (CRWV) Stock: Two Insiders Sell Over $45 Million in One Day appeared first on CoinCentral.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags: